Form 4: Solen Therapeutics Executive Sells Shares to Cover Tax Obligations

Patricia C. Hirano, a Senior Vice President at Soleno Therapeutics, sold shares of common stock on April 1, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On April 1, 2024, Patricia C. Hirano, Senior Vice President at Soleno Therapeutics, sold 1,330 shares of common stock at a weighted average price of $41.1227.
• Hirano also sold 888 shares of common stock at a weighted average price of $41.6671 on the same day.
• These sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Following these transactions, Hirano beneficially owns 50,924 shares of Soleno Therapeutics common stock, some of which are RSUs representing a contingent right to receive one share of common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (stock sale for tax obligations) and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking to understand the sentiment and actions of those with the most knowledge of the company.

Stakeholder Impact

• The stock sales may have a minor, temporary impact on the stock price due to the increased selling volume.

Key Dates